Alcon AG (ALC)
75.74
-2.04
(-2.62%)
USD |
NYSE |
Mar 18, 16:00
74.59
-1.15
(-1.52%)
Pre-Market: 06:52
Alcon EPS Diluted (Quarterly) : 0.4407 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STAAR Surgical Co. | -0.368 |
| Novartis AG | 1.249 |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
| Basilea Pharmaceutica AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 217.00M |
| Revenue (Quarterly) | 2.718B |
| Total Expenses (Quarterly) | 2.501B |
| Enterprise Value | 40.56B |
| Gross Profit Margin (Quarterly) | 55.78% |
| Profit Margin (Quarterly) | 7.98% |
| Earnings Yield | 2.61% |
| Operating Earnings Yield | 3.95% |
| Normalized Earnings Yield | 2.754 |